Abstract
IN VITRO BIOLOGICAL ACTIVITY ASSESSMENT OF RHEPO PHARMACEUTICAL FORMULATIONS FOR BATCH RELEASE

Asmaa O. Sana-Eldine*, O. Khamiss and Nahla S. Kotb

ABSTRACT

Background: Recombinant human erythropoietin (rhEPO) is the pharmaceutical form of erythropoietin (EPO), used for the treatment of chronic kidney disease and cancer-associated anemia, act as a growth proliferation factor for cells having EPO- receptor on their surfaces such as blood progenitors, non-hematopoietic cells and some types of tumor cells. Methodology: This study is objectively planned for in vitro biological assessment of rhEPO activity as a routine quality control testing, instead of in vivo animal testing. Malignant cell lines such as MCF-7, HepG2, HELA and PC3 were subjected as expermental cells in this study. Growth rate response for rhEPO treatment was estimated by MTT- based bioassay then was confirmed by hemacytometer and microscopical observation. Results: Statistical records reflected that rhEPO at concentration of 0.78 IU/ml to 25 IU/ml causes cell proliferation expontionally at r >0.9. Using single factor ANOVA (T-test), there is a significant cell proliferation at p <0.005 comparing with non-treated cells. Conclusion: Cell proliferation corresponding to rhEPO can be used as a new approach for quality control testing of rhEPO pharmaceutical products.

Keywords: hemacytometer and microscopical.


[Full Text Article]

Login





Forgot Password  |  Register

Indexing

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Tangudu Nagabhusana Rao

Download Article : Click here

News & Updation

  • NEW OCTOBER ISSUE PUBLISHED

    OCTOBER 2020 Issue has been successfully launched on 1 October 2020.

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT